New comp plan

Discussion in 'Synthes' started by anonymous, Nov 13, 2019 at 4:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Has anyone heard any details about the new trauma comp plan? 9% base w a massive growth number was what I was told
     

  2. anonymous

    anonymous Guest

    Ouch, down to 9%..............really glad I left when it went from 12.5% to 11.0%. I would love to hear KC "sell" this to the field.
     
  3. anonymous

    anonymous Guest

    Not sure your source. My manager has told our team the comp plan will stay the same as 2019
     
  4. anonymous

    anonymous Guest

    It’s like we don’t have enough external battles to deal with, Now I and others will have to go work for our competition. It’s a dangerous game to play and could end up like spine. They ego’d themselves out of Wright
    now cuts. I’ll be looking on from the outside. Good things don’t ever last here.
     
  5. anonymous

    anonymous Guest

    So have we confirmed it’s being cut to 9%?
     
  6. anonymous

    anonymous Guest

    9% w 22% growth carrot. Sorry losers, no more getting paid to just cover cases. Of course this was going to happen!
     
  7. anonymous

    anonymous Guest


    So for a 2MM territory you’ll need 9% growth to break even vs the old comp plan. No small task.
     
  8. anonymous

    anonymous Guest

    Is this really true on the comp plan? With this comp plan your growth rate would have to increase every year to make more than the old comp plan. In an age of pricing pressures, this is impossible. JnJ wins in long run as cost to sales continues to decrease. I feel they just look for ways to drop rep income gradually over time. No wonder every decent rep leaves
     
  9. anonymous

    anonymous Guest

    Exactly, "leadership" won't be happy until rep income averages <$150K (maybe even less) because they think we're just set jockeys.
     
  10. anonymous

    anonymous Guest

    Have I missed something? Haven’t heard anything about this.
     
  11. anonymous

    anonymous Guest

    Comp plan is not significantly changing. Like all companies, the comp plan is evaluated this time of year to be the most competitive in the medical device business and we will continue to pay sales reps market rate and market leading compensation. You'll get an email from me very soon but until then please stay focused on closing out a successful 2019 sales year. Thank you,
     
  12. anonymous

    anonymous Guest

    HAHAHAH! I wouldnt be surprised if they did send an email like this.
     
  13. anonymous

    anonymous Guest

    It’s not significantly changing, just moving from 11% to 9%....just like when it was 12.5% to 11%. Super simple
     
  14. anonymous

    anonymous Guest

    Is this comp plan change for real?? This sucks!
     
  15. anonymous

    anonymous Guest

    So far just competitive misinformation
     
  16. anonymous

    anonymous Guest

    Yea but where getting In storage used JNJ Pharma Rep cars in 2020
     
  17. anonymous

    anonymous Guest

    The 2020 compensation plan will be unveiled on Friday the 13th at 1230pm. Stay tuned!
     
  18. anonymous

    anonymous Guest

    My manager told me that I shouldn’t worry too much. Since they are trying to build cmf back up, significant comp changes are unlikely bc they can’t afford to lose any more reps to the competition. I was told that if growth can’t be achieved within the next 12 months or so, comp will change drastically and managers could be under a scary/serious reorganization. I get worn out on all the changes JnJ makes every year. I miss the boring, stable days of Synthes. What a fantastic company. I wish Hansjorg didn’t sell to JnJ. Now it’s a total shit show
     
  19. anonymous

    anonymous Guest


    Comp already changed drastically when we went from 12.5 to 11.0.

    I would love to know of the roughly 12,500 Synthes employees at the time of the “merger”, how many are still with DPS, and of those still with DPS, how many consider themselves to be in an equal or better position at this point ?

    I would guess of the 12,500 Synthes employees, 90% preferred working for Synthes, a company the average person never heard of, vs JNJ, just another $ mongering corporate behemoth.
     
  20. anonymous

    anonymous Guest

    Mr Incredible may know the answer to that